Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

被引：0
|
作者：
Igawa, S. [1 ]
Fukui, T. [1 ]
Shirasawa, M. [1 ]
Ozawa, T. [1 ]
Sone, H. [1 ]
Kusuhara, S. [1 ]
Nishinarita, N. [1 ]
Hiyoshi, Y. [1 ]
Kubota, M. [1 ]
Mitsufuji, H. [2 ]
Sasaki, J. [3 ]
Katagiri, M. [4 ]
Naoki, K. [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Small Cell Lung Cancer; Elderly patients; Performance status; Amrubicin;
D O I：
10.1016/j.jtho.2018.08.837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.12-02
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer
    Matsukida, Akira
    Imai, Hisao
    Shiono, Ayako
    Ryuno, Yasuhiro
    Hashimoto, Kosuke
    Miura, Yu
    Endo, Satoshi
    Okazaki, Shohei
    Yamaguchi, Ou
    Mouri, Atsuto
    Abe, Takanori
    Kaira, Kyoichi
    Kobayashi, Kunihiko
    Kato, Shingo
    Kagamu, Hiroshi
    ANTICANCER RESEARCH, 2025, 45 (02) : 733 - 741
  • [42] The safety and efficacy of amrubicin in the treatment of previously untreated extensive-disease small-cell lung cancer: a meta-analysis
    Wu, Ji-Feng
    Zhou, Jian-Jun
    Li, Xin-Ai
    Hu, Li-Hui
    Wen, Meng-Li
    ONCOTARGETS AND THERAPY, 2019, 12 : 5135 - 5142
  • [43] Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer
    Asao, Tetsuhiko
    Nokihara, Hiroshi
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Yamamoto, Noboru
    Sekine, Ikuo
    Kunitoh, Hideo
    Fujiwara, Yutaka
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 941 - 946
  • [44] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    IN VIVO, 2019, 33 (01): : 163 - 166
  • [45] Phase II Study of Sequential Triplet Chemotherapy, Irinotecan and Cisplatin Followed by Amrubicin, in Patients with Extensive-Stage Small Cell Lung Cancer: West Japan Thoracic Oncology Group Study 0301
    Kobayashi, Masashi
    Matsui, Kaoru
    Iwamoto, Yasuo
    Ebi, Noriyuki
    Oizumi, Satoshi
    Takeda, Koji
    Sawa, Toshiyuki
    Shibata, Kazuhiko
    Saka, Hideo
    Imamura, Fumio
    Seki, Nobuhiko
    Saito, Hiroshi
    Goto, Isao
    Nakagawa, Kazuhiko
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (07) : 1075 - 1080
  • [46] Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer
    Wakuda, Kazushige
    Kobayashi, Haruki
    Omori, Shota
    Nakashima, Kazuhisa
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Takahashi, Toshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (09) : 822 - 826
  • [47] EFFICACY OF AMRUBICIN IN PATIENTS WITH REFRACTORY RELAPSED SMALL CELL LUNG CANCER
    Wakuda, Kazushige
    Kenmotsu, Hirotsugu
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Kimura, Madoka
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Shukuya, Takehito
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S493 - S494
  • [48] Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer
    Chen, YM
    Wu, MF
    Perng, RP
    Chou, CM
    Yang, KY
    Lin, WC
    Tsai, CM
    Liu, JM
    WhangPeng, J
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (02) : 76 - 79
  • [49] Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer
    Hotta, K
    Takigawa, N
    Kiura, K
    Tabata, M
    Umemura, S
    Ogino, A
    Uchida, A
    Bessho, A
    Segawa, Y
    Shinkai, T
    Nogami, N
    Harita, S
    Okimoto, N
    Ueoka, H
    Tanimoto, M
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2429 - 2434
  • [50] A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer CALGB 30104
    Govindan, Ramaswamy
    Wang, Xiaofei
    Baggstrom, Maria Q.
    Burdette-Radoux, Susan
    Hodgson, Lydia
    Vokes, Everett E.
    Green, Mark R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 220 - 226
12345